News

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Public Broadcasting Service (PBS)4d
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a year
A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...
US approves twice-yearly injection for HIV prevention. What you need to know about lenacapavir
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
Gilead’s HIV Breakthrough
Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
San Francisco Examiner1h
Coverage questions mute enthusiasm for HIV drug approval
Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...
KUNC1d
FDA approves HIV medication Lenacapavir, but it's costly
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
KSL1d
FDA approves HIV drug based on University of Utah biochemist's findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
Wasted miracle? Concerns as revolutionary HIV drug approved
The US has approved lenacapavir for HIV prevention. But experts worry that cuts to the health budget will 'squander' the drug ...
CNN7d
FDA approves twice-a-year injection for HIV prevention - CNN
Another study, the PURPOSE 1 trial, found that lenacapavir demonstrated 100% efficacy for HIV prevention in women. “Lenacapavir is a unique option for people for HIV prevention because it’s an ...